PPARA and urinary bladder carcinoma: For example, Lin et al. demonstrated that fluoxetine at concentrations from 5 to10 μM could activate peroxisome proliferator-activated receptor alpha (PPAR-α) and further cause G1 arrest and growth inhibition in human bladder carcinoma cell (T24) [28].